These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26 related articles for article (PubMed ID: 39119787)
1. The activity of selective sigma-1 receptor ligands in seizure models in vivo. Vavers E; Svalbe B; Lauberte L; Stonans I; Misane I; Dambrova M; Zvejniece L Behav Brain Res; 2017 Jun; 328():13-18. PubMed ID: 28389336 [TBL] [Abstract][Full Text] [Related]
2. Fenfluramine acts as a positive modulator of sigma-1 receptors. Martin P; de Witte PAM; Maurice T; Gammaitoni A; Farfel G; Galer B Epilepsy Behav; 2020 Apr; 105():106989. PubMed ID: 32169824 [TBL] [Abstract][Full Text] [Related]
3. Pharmacological Profile of the Novel Antiepileptic Drug Candidate Padsevonil: Characterization in Rodent Seizure and Epilepsy Models. Leclercq K; Matagne A; Provins L; Klitgaard H; Kaminski RM J Pharmacol Exp Ther; 2020 Jan; 372(1):11-20. PubMed ID: 31619464 [TBL] [Abstract][Full Text] [Related]
4. A face-to-face comparison of the intra-amygdala and intrahippocampal kainate mouse models of mesial temporal lobe epilepsy and their utility for testing novel therapies. Welzel L; Schidlitzki A; Twele F; Anjum M; Löscher W Epilepsia; 2020 Jan; 61(1):157-170. PubMed ID: 31828786 [TBL] [Abstract][Full Text] [Related]
5. The cognition-enhancing activity of E1R, a novel positive allosteric modulator of sigma-1 receptors. Zvejniece L; Vavers E; Svalbe B; Vilskersts R; Domracheva I; Vorona M; Veinberg G; Misane I; Stonans I; Kalvinsh I; Dambrova M Br J Pharmacol; 2014 Feb; 171(3):761-71. PubMed ID: 24490863 [TBL] [Abstract][Full Text] [Related]
6. Preclinical efficacy profiles of the sigma-1 modulator E1R and of fenfluramine in two chronic mouse epilepsy models. Pérez-Pérez D; Monío-Baca C; von Rüden EL; Buchecker V; Wagner A; Schönhoff K; Zvejniece L; Klimpel D; Potschka H Epilepsia; 2024 Aug; 65(8):2470-2482. PubMed ID: 39119787 [TBL] [Abstract][Full Text] [Related]
7. Pharmacology of glutamate receptor antagonists in the kindling model of epilepsy. Löscher W Prog Neurobiol; 1998 Apr; 54(6):721-41. PubMed ID: 9560847 [TBL] [Abstract][Full Text] [Related]
8. Allosteric Modulators of Sigma-1 Receptor: A Review. Vavers E; Zvejniece L; Maurice T; Dambrova M Front Pharmacol; 2019; 10():223. PubMed ID: 30941035 [TBL] [Abstract][Full Text] [Related]
9. Validated animal models for antiseizure drug (ASD) discovery: Advantages and potential pitfalls in ASD screening. Barker-Haliski M; Steve White H Neuropharmacology; 2020 May; 167():107750. PubMed ID: 31469995 [TBL] [Abstract][Full Text] [Related]
10. Levetiracetam: the preclinical profile of a new class of antiepileptic drugs? Klitgaard H Epilepsia; 2001; 42 Suppl 4():13-8. PubMed ID: 11564119 [TBL] [Abstract][Full Text] [Related]
11. Fenfluramine repurposing from weight loss to epilepsy: What we do and do not know. Odi R; Invernizzi RW; Gallily T; Bialer M; Perucca E Pharmacol Ther; 2021 Oct; 226():107866. PubMed ID: 33895186 [TBL] [Abstract][Full Text] [Related]
12. Animal models of epilepsy for the development of antiepileptogenic and disease-modifying drugs. A comparison of the pharmacology of kindling and post-status epilepticus models of temporal lobe epilepsy. Löscher W Epilepsy Res; 2002 Jun; 50(1-2):105-23. PubMed ID: 12151122 [TBL] [Abstract][Full Text] [Related]